Economic Considerations for Complement-Medicated Disorders

Our mission is to transform the lives of people living with rare diseases and devastating conditions through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. By continuing to deepen our understanding of rare disease, which began with our pioneering work in complement biology, we are able to innovate and evolve into new areas where there is great unmet need and opportunity to help patients and families fully live their best lives.

For more information and to register for the Boardroom Sessions at the IDN Summit Virtual Experience, please contact Robert Chafin at 859.523.5701.